Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gender effects on plasma PGRN levels in patients with Alzheimer's disease: a preliminary study.

Journal of Alzheimer's disease : JAD - 1 Jan 2013

Piscopo Paola, Rivabene Roberto, Galimberti Daniela, Crestini Alessio, Talarico Giuseppina, Vanacore Nicola, Scarpini Elio, Bruno Giuseppe, Confaloni Annamaria

Abstract excerpt

Plasma progranulin (PGRN) levels constitute a potentially invaluable biomarker for neurodegenerative diseases including frontotemporal lobar degeneration (FTLD) and, perhaps, Alzheimer's disease (AD). We assessed plasma PGRN levels in 107 AD patients, 36 FTLD patients, and 107 controls. We found...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aging
Share to Enzyme-Linked Immunosorbent Assay
Share to Intercellular Signaling Peptides and Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neuropsychological Tests

Share to Pilot Projects

Share to Progranulins

Share to Psychiatric Status Rating Scales

Share to Sex Characteristics

Source

Identifiers

PMID: 23396349
DOI: 10.3233/JAD-121606

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23396349-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Gender effects on plasma PGRN levels in patients with Alzheimer's disease: a preliminary study.PMID 23396349Read ↗

The Role of PGRN in Alzheimer’s DiseaseSemantic proximity Read ↗

A Sex Perspective in Neurodegenerative Diseases: microRNAs as Possible Peripheral BiomarkersSemantic proximity Read ↗

Progranulin protein levels are differently regulated in plasma and CSF.Semantic proximity Read ↗

Progranulin Protein Levels in Cerebrospinal Fluid in Primary Neurodegenerative Dementias.Semantic proximity Read ↗

Serum progranulin levels in patients with frontotemporal lobar degeneration and Alzheimer's disease: detection of GRN mutations in a Spanish cohort.Semantic proximity Read ↗

Role of progranulin as a biomarker for Alzheimer's disease.Semantic proximity Read ↗

Plasma progranulin levels for frontotemporal dementia in clinical practice: a 10-year French experience.Semantic proximity Read ↗

Serum progranulin is not associated with rs5848 polymorphism in Korean patients with neurodegenerative diseases.Semantic proximity Read ↗

Allopregnanolone levels are reduced in temporal cortex in patients with Alzheimer's disease compared to cognitively intact control subjects.Semantic proximity Read ↗

Loss of Lysosomal Proteins Progranulin and Prosaposin Associated with Increased Neurofibrillary Tangle Development in Alzheimer Disease.Semantic proximity Read ↗

Alzheimer's risk associated with human apolipoprotein E, alpha-2 macroglobulin and lipoprotein receptor related protein polymorphisms: absence of genetic interactions, and modulation by gender.Semantic proximity Read ↗

Progranulin peripheral levels as a screening tool for the identification of subjects with progranulin mutations in a Portuguese cohort.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.